Adoptive immunotherapy of cancer using CD4+ T cells

P Muranski, NP Restifo - Current opinion in immunology, 2009 - Elsevier
CD4+ T cells are central to the function of the immune system but their role in tumor
immunity remains underappreciated. It is becoming clear that there is an enormous diversity …

MHC class I antigens and immune surveillance in transformed cells

N Aptsiauri, T Cabrera, A Garcia‐Lora… - International review of …, 2007 - Elsevier
MHC class I antigens play a crucial role in the interaction of tumor cells with the host immune
system, in particular, in the presentation of peptides as tumor‐associated antigens to …

Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer

PF Brunsvig, S Aamdal, MK Gjertsen… - Cancer Immunology …, 2006 - Springer
Abstract Purpose: A phase I/II study was conducted to investigate the safety, tolerability and
clinical response to vaccination with a combination of telomerase peptides GV1001 (hTERT …

Chemoattractant receptors BLT1 and CXCR3 regulate antitumor immunity by facilitating CD8+ T cell migration into tumors

ZS Chheda, RK Sharma, VR Jala… - The Journal of …, 2016 - journals.aai.org
Immunotherapies have shown considerable efficacy for the treatment of various cancers, but
a multitude of patients remain unresponsive for various reasons, including poor homing of T …

[HTML][HTML] Immune surveillance of acute myeloid leukemia is mediated by HLA-presented antigens on leukemia progenitor cells

A Nelde, H Schuster, JS Heitmann, J Bauer… - Blood Cancer …, 2023 - AACR
Therapy-resistant leukemia stem and progenitor cells (LSC) are a main cause of acute
myeloid leukemia (AML) relapse. LSC-targeting therapies may thus improve outcome of …

Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine

C Grossardt, CE Engeland, S Bossow… - Human gene …, 2013 - liebertpub.com
Oncolytic measles viruses (MV) derived from the live attenuated vaccine strain have been
engineered for increased antitumor activity, and are currently under investigation in clinical …

[HTML][HTML] Immune escape mechanisms and immunotherapy of urothelial bladder cancer

Z Yang, Y Xu, Y Bi, N Zhang, H Wang… - Journal of clinical and …, 2021 - ncbi.nlm.nih.gov
Methods: Based on a comprehensive search of the PubMed and ClinicalTrials. gov
database, this review included the literature reporting the immune escape mechanisms of …

[HTML][HTML] Cancer and stress: does it make a difference to the patient when these two challenges collide?

A Iftikhar, M Islam, S Shepherd, S Jones, I Ellis - Cancers, 2021 - mdpi.com
Simple Summary Head and neck cancers are the sixth most common cancer in the world.
The burden of the disease has remained challenging over recent years despite the …

Cancer therapy and vaccination

HAA Aly - Journal of immunological methods, 2012 - Elsevier
Cancer remains one of the leading causes of death worldwide, both in developed and in
developing nations. It may affect people at all ages, even fetuses, but the risk for most …

New directions in chimeric antigen receptor T cell [CAR‐T] therapy and related flow cytometry

E Maryamchik, KME Gallagher, FI Preffer… - Cytometry Part B …, 2020 - Wiley Online Library
Chimeric antigen receptor (CAR) T cells provide a promising approach to the treatment of
hematologic malignancies and solid tumors. Flow cytometry is a powerful analytical …